News and Events

SunSmart behaviours of outdoor socialisers

14 February 2020

The Health Promotion Agency/Te Hiringa Hauora (HPA) has undertaken some research to provide insight into attitudes, awareness and concern toward ultra-violet (UVR) radiation, primarily for outdoor socialisers in the age group of 18-24 years. The research findings identified that despite outdoor socialisers having a high awareness of identified/known SunSmart behaviours, it does not always translate into using SunSmart behaviours. 

Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018

14 February 2020

The national health service in England has comprehensive databases which were used in this study to track prescribing of checkpoint inhibitors (CPIs) approved for first line use in metastatic melanoma and determine patient outcomes associated with survival and treatment toxicity. This largest real world dataset demonstrated rapid uptake of CPIs and survival outcomes similar to randomized clinical trials (RCTs). 

Systemic Therapy for Mucosal, Acral, and Uveal Melanoma

12 February 2020

This chapter reviews the clinical, molecular, and immunological characteristics of acral, mucosal, and uveal melanoma in the context of systemic therapy in both the advanced disease setting as well as the adjuvant setting. It also contains a review of emerging data on new therapeutic options and the use of systemic therapy in additional clinical settings such as in the neoadjuvant setting.